VistaGen Therapeutics Company

VistaGen is a biopharmaceutical company developing innovative product candidates for patients with diseases and disorders involving the CNS.
Technology: Stem cell therapy
Industry: Public
Headquarters: San Francisco, California, United States
Founded Date: 1998-01-01
Employees Number: 11-50
Funding Status: IPO
Investors Number: 2
Total Funding: 54750281
Estimated Revenue: $1M to $10M
Last Funding Date: 2016-06-02
Last Funding Type: Post-IPO Equity

Visit Website
investor.relations@vistagen.com
http://twitter.com/vistagen
Register and Claim Ownership